Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LSS | P48449 | 10/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL119016 | 1.00 | LSS (0.58) | LSS | |
| SCHEMBL1704748 | 1.00 | LSS (0.58) | LSS | |
| SCHEMBL727892 | 0.93 | LSS (0.51) | LSS | |
| SCHEMBL119229 | 0.88 | LSS (0.46) | LSS | |
| SCHEMBL7191948 | 0.88 | LSS (0.46) | LSS | |
| SCHEMBL8767769 | 0.88 | LSS (0.46) | LSS | |
| SCHEMBL8767763 | 0.88 | LSS (0.46) | LSS | |
| SCHEMBL7191953 | 0.88 | LSS (0.46) | LSS | |
| SCHEMBL4435563 | 0.86 | LSS (0.56) | LSS | |
| SCHEMBL1705558 | 0.86 | LSS (0.56) | LSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022166842-A1 | COMPOSITION COMPRISING BENZYLAMINE ACARICIDE AND USE THEREOF | 山东康乔生物科技有限公司 | 2022-08-11 | — | — | WO | claimed |
| US-20060035873-A1 | Methods for inducing apolipoprotein e secretion | ILEX PRODUCTS, INC. | 2006-02-16 | — | — | US | claimed |
| EP-1019059-A4 | USE OF FXR, PPARalpha AND LXRalpha ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION | UNIV CALIFORNIA (US) | 2004-01-14 | — | — | EP | claimed |
| JP-2001509165-A | — | — | 2001-07-10 | — | — | JP | claimed |
| US-6187814-B1 | BY TOPICALLY AN FARNESOID X-ACTIVATED RECEPTOR (FXR) ACTIVATOR SELECTED FROM FARNESAL, ALKYL FARNESYL ETHER, ALKYL FARNESOATE, AND 7-METHYL-9-(3,3-DIMETHYLOXIRANYL)-3-METHYL-2,6-NONADIENOIC ACID, ALKYL ESTER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-02-13 | — | — | US | claimed |
| WO-2000049992-A2 | USE OF FXR, PPARα AND LXRα ACTIVATORS TO TREAT ACNE/ACNEIFORM CONDITIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-08-31 | — | — | WO | claimed |
| EP-1019059-A1 | USE OF FXR, PPARalpha AND LXRalpha ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-07-19 | — | — | EP | claimed |
| US-6071955-A | TREATING TERRESTRIAL MAMMALIAN SUBJECT SUFFERING FROM A CONDITIONS OF ACNE AND ACNEIFORM CONDITIONS BY ADMINISTERING 7-METHYL-9-(3,3-DIMETHYLOXIRANYL)-3-METHYL-2,6-NONADIENOIC ACID METHYL ESTER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-06-06 | — | — | US | claimed |
| WO-1998032444-A1 | USE OF FXR, PPARα AND LXRα ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-07-30 | — | — | WO | claimed |
| CN-122036637-A | Polymorphs | 先正达农作物保护股份公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260020567-A1 | CRYSTALLINE FORMS OF 1,2,4-OXADIAZOLE FUNGICIDES | SYNGENTA CROP PROTECTION AG (CH) | 2026-01-22 | — | — | US | disclosed |
| US-20250241304-A1 | FUNGICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2025-07-31 | — | — | US | disclosed |
| CN-120019749-A | Spraying bias flow aid | 禾大国际股份公开有限公司 | 2025-05-20 | — | — | CN | disclosed |
| CN-119998270-A | Microbiocidal pyrazole derivatives | 先正达农作物保护股份公司 | 2025-05-13 | — | — | CN | disclosed |
| EP-1019059-A1 | USE OF FXR, PPARalpha AND LXRalpha ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-07-19 | — | — | EP | disclosed |
| US-6071955-A | TREATING TERRESTRIAL MAMMALIAN SUBJECT SUFFERING FROM A CONDITIONS OF ACNE AND ACNEIFORM CONDITIONS BY ADMINISTERING 7-METHYL-9-(3,3-DIMETHYLOXIRANYL)-3-METHYL-2,6-NONADIENOIC ACID METHYL ESTER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-06-06 | — | — | US | disclosed |
| US-6071955-A | TREATING TERRESTRIAL MAMMALIAN SUBJECT SUFFERING FROM A CONDITIONS OF ACNE AND ACNEIFORM CONDITIONS BY ADMINISTERING 7-METHYL-9-(3,3-DIMETHYLOXIRANYL)-3-METHYL-2,6-NONADIENOIC ACID METHYL ESTER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-06-06 | — | — | US | disclosed |
| US-6060515-A | TOPICALLY APPLYING TO MAMMALIAN SKIN OR MUCOUS MEMBRANE A BARRIER DEVELOPMENT ENHANCING AMOUNT OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPARA) | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-05-09 | — | — | US | disclosed |
| US-6005086-A | WHEREIN SAID POLYPEPTIDE IS A NUCLEAR RECEPTOR AND IS RESPONSIVE TO THE PRESENCE OF FARNESOID TO REGULATE THE TRANSCRIPTION OF ASSOCIATED GENE(S) | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1999-12-21 | — | — | US | disclosed |
| WO-1998032444-A1 | USE OF FXR, PPARα AND LXRα ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-07-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260020567-A1 | CRYSTALLINE FORMS OF 1,2,4-OXADIAZOLE FUNGICIDES | CYP51A1, CYP4B1, CYP8B1 | LSS 67/4885 |
| US-20250241304-A1 | FUNGICIDAL COMPOUNDS | CYP1B1, CYP51A1, CYP1A1 | LSS 73/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.